Şunu aradınız:: leukocytopeni (İsveççe - İngilizce)

basofil leukocytopeni
basopenia

leukocytopeni, trombocytopeni
leukocytopenia, thrombocytopenia

leukocytopeni. trombocytopeni.
leucopenia thrombocytopenia

leukocytopeni Ökad blödningstid
leucopoenia

trombocytopeni, leukocytopeni, granulocytopeni
thrombocytopenia, leucopenia, granulocytopenia

leukocytopeni, neutropeni, anemi *
hypersensitivity reaction anorexia

mycket sällsynta: leukocytopeni, trombocytopeni
very rare: leukocytopenia, thrombocytopenia

agranulocytos, anemi, leukocytopeni, trombocytopeni, neutropeni
agranulocytosis, anaemia, leukocytopenia, thrombocytopenia, neutropenia

leukocytopeni har rapporterats hos 8 till 12 % av patienterna.
leucopoenia has been reported in 8 to 12 % of patients.

andra vanliga biverkningar omfattar trombocytopeni, leukocytopeni och granulocytopeni.
other common adverse reactions include thrombocytopenia, leucopenia, and granulocytopenia.

blodet och lymfsystemet vanliga: trombocytopeni, leukocytopeni, granulocytopeni mindre vanliga: leukocytos
blood and lymphatic system disorders common: thrombocytopenia, leucopenia, granulocytopenia uncommon: leukocytosis

nedsatt urinsyra i blodet Ökade leverenzymer undersökningar Ökat plasmakolesterol Ökade plasmatriglycerider anemi blodet och lymfsystemet leukocytopeni trombocytopeni Ökad blödningstid
elevated liver enzymes plasma cholesterol increased plasma triglycerides increased

det rekommenderas att antalet blodplättar och vita blodkroppar kontrolleras regelbundet, eftersom enstaka fall av reversibel trombocytopeni och leukocytopeni har observerats vid klinisk utvärdering.
it is recommended that platelet and wbc counts are monitored regularly, as a few cases of reversible thrombocytopenia and leucopenia were observed during clinical evaluation.

Övervakning av blodplättar och vita blodkroppar (wbc) det rekommenderas att antalet blodplättar och vita blodkroppar kontrolleras regelbundet, eftersom enstaka fall av reversibel trombocytopeni och leukocytopeni har observerats vid klinisk utvärdering.
platelet and white blood cell (wbc) monitoring it is recommended that platelet and white cell counts are monitored regularly, as a few cases of reversible trombocytopenia and leucopenia were observed during clinical evaluation.

minskat antal blodplättar (trombocytopeni) och vita blodkroppar (leukocytopeni), brist på vissa vita blodkroppar (granulocytopeni).
reduced number of platelets (thrombocytopenia) and white blood cells (leukopenia), shortage of certain white blood cells (granulocytopenia).

de vanligaste biverkningarna (uppträder hos fler än 1 av 10 patienter) är anemi (lågt antal röda blodkroppar), leukocytopeni och neutropeni (lågt antal vita blodkroppar), trombocytopeni (lågt antal blodplättar), asteni (svaghet), pyrexi (feber), rigor (stelhet) och illamående.
the most common side effects with zevalin (seen in more than 1 patient in 10) are anaemia (low red blood cell counts), leucocytopenia and neutropenia (low white blood cell counts), thrombocytopenia (low blood platelet counts), asthenia (weakness), pyrexia (fever), rigors (stiffness) and nausea (feeling sick).